Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
The practice of medicine is more than just prescribing medicines / Cameron Nutt, Medical Student, HMS
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Education Matters with Cameron Nutt
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Interim Report Update: Genova Property Group’s Performance and Future Outlook | Michael Moschewitz, CEO , Genova Property Group AB.
00:10:00
Empowering Green Transition: A Call to Action for Future Generations | Simona Grossi, CEO, Greenthesis Spa.
00:00:00
Interview with Alan Clarke, CEO Abano Healthcare Limited
00:10:00
A snapshot highlights the movement of stocks for TASK Group Holdings (ASX), Reach Resources (ASX& RR1O), and Archer Materials.|Daniel Houden is Chief Executive Officer & Executive Director of TASK Group Holdings Ltd.
00:10:00
Blue Bonds: Unlocking the Blue Economy's Potential - Insights from Matt Lawton and Tongai Kunorubwe at T. Rowe Price
00:10:00
Transparency and Visibility: The Power of AP Automation | Annie Hackman Schrenk , Director Sales & Marketing AT Top Image System
00:10:00
James Clifton, CEO of The MISSION Group, discusses company insights in an executive interview with Mirriad Advertising.
00:10:00
Breaking down stigmas and biases in venture capital affecting female founders|Jesse Draper,General Partner,Halogen Ventures
00:10:00
Granite City Food & Brewery: A Warm Welcome to Exceptional Dining
00:10:00
Gold Terra Resource Corp is Creating Value with the Drill Bit | Gerald Panneton, Chairman andCEO, Gold Terra Resource Corp. (IE)
00:10:00
Addressing Global Challenges: Perspectives from Norfund CEO Tellef Thorleifsson | Tellef Thorleifsson, CEO, Norfund.
00:10:00
Trading of Caverion Oyj shares (trading symbol: CAV1V) commenced on the NASDAQ OMX Helsinki Main Market on July 1, 2013.